Objective: To examine the associations of maternal hemoglobin and hematocrit levels during pregnancy with childhood lung function and asthma, and whether adverse pregnancy outcomes and atopic predisposition modify the associations.
viscosity resulting in an impaired blood flow through the placenta. 12 Subsequently, insufficient oxygen supply could affect fetal growth and lung development, 5, 6, [13] [14] [15] and increase the risk of chronic obstructive respiratory diseases in later life. 16, 17 Human cohort studies that examined associations of maternal hemoglobin and hematocrit status with asthma-related outcomes in childhood are scarce, and report inconsistent results. 16, 17 A prospective cohort study among 597 children and their mothers showed that maternal anemia based on hemoglobin levels at any time during pregnancy was associated with an increased risk of infant wheezing and childhood asthma. 16 In contrast, we previously observed no association of maternal hemoglobin levels during pregnancy with wheezing from birth to age 6 years, ever physician-diagnosed asthma, or change in respiratory resistance (Rint) and fractional exhaled nitric oxide (FeNO) at 6 years. 17 Differences in results of these studies might be explained by differences in type of measurement of hemoglobin or hematocrit levels, definitions of anemia such as hemoglobin level lower than 11 or 10.5 g/dL, type of lung function measures such as Rint, FeNO, or peak expiratory flow, definitions of asthma such as wheezing, ever or current asthma, ages at time of assessment, or adjustment for confounders. Moreover, the role of socio-economic and lifestyle factors, adverse pregnancy outcomes and atopic predisposition on the association of maternal hemoglobin and hematocrit status during pregnancy with asthma-related outcomes in children is not fully clear. 4, 18 Therefore, we examined the associations of maternal hemoglobin and hematocrit levels during pregnancy with lung function measures and asthma among 3672 children participating in a population-based prospective cohort, and whether these associations were explained by lifestyle and socio-economic factors or modified by adverse pregnancy outcomes and atopic predisposition.
2 | METHODS
| Design
This study was embedded in the Generation R Study, a prospective population-based cohort study from early fetal life onwards in Rotterdam, the Netherlands. [19] [20] [21] The study was approved by the Medical Ethical Committee of the Erasmus MC, University Medical Centre Rotterdam, the Netherlands. Written informed consent was obtained from all participants. A total of 3672 mothers and their children were included for the current analyses ( Fig. 1 ).
| Maternal hemoglobin and hematocrit levels during pregnancy
As previously described, we assessed maternal serum hemoglobin and hematocrit levels from fresh EDTA plasma samples obtained by maternal venous blood samples at enrolment. 15 Of all blood samples, >80% and child day care attendance in the first year of life) and biological factors (maternal smoking, atopy and asthma family history, mode of delivery, gestational age at birth, breastfeeding, and maternal weight and height at enrolment). Non-linear associations were tested by adding the quadratic term for hemoglobin and hematocrit levels in the models. We used similar regression analyses for the associations of low and elevated hemoglobin and hematocrit levels with lung function measures and current asthma, using normal hemoglobin and hematocrit levels as reference categories. Last, effect modification due to adverse pregnancy outcomes (caesarian section, lower gestational age, or weight at birth), and atopic predisposition factors (maternal history of asthma or atopy and child's allergic sensitization) were examined in the fully adjusted models by adding the product term between the determinant and the covariate in the statistical models.
We used the F-statistic to test the model fit of models with and without interaction terms. P values for F-statistics <0.05 were considered significant, indicating a different model fit when comparing the models with and without interaction terms. All measures of association are presented with their 95% Confidence Intervals (95%CI). Statistical analyses were performed using SPSS version 21.0
for Windows software (SPSS Inc, Chicago, IL).
| RESULTS
Maternal and child characteristics are presented in Table 1 2.71 L/s (SD ± 0.64), and 1.14 L/s (SD ± 0.34), respectively. Current asthma was observed in 7.2% of the participants. Compared with those included in our study, we observed that mothers not included in the study were younger, more often multiparous, had a higher prepregnancy BMI, more often had gestational hypertensive disorders, less often used folic acid supplementation and alcohol during pregnancy, more often had caesarean-section as mode of delivery of their child, and that children were born at an earlier gestational age (P values <0.01) (Table S1 ).
| Hemoglobin and hematocrit levels and respiratory outcomes
The crude model showed that higher maternal hemoglobin levels were associated with lower FEF 
| DISCUSSION
In this population-based prospective birth cohort study, we observed that higher maternal hematocrit levels during pregnancy, both continuously and categorized according to clinical cut-offs, were associated with 
| Comparison with previous studies
Prospective cohort studies that assessed the association of maternal hemoglobin or hematocrit levels with childhood lung function and asthma are scarce, 16, 17 and show inconsistent results. We aimed to address all factors that explained differences in results of the previous studies into account, and now used both hemoglobin and hematocrit levels, WHO clinical cut-off definitions, lung function measured by spirometry, which is an objective and reliable 29, 30 method, took gestational age at blood sampling and multiple confounders into account, and explored intermediating and effect modifying factors. We observed associations of maternal hemoglobin and hematocrit levels measured in early pregnancy with lower childhood lung function, but not with asthma at age 10 years. A population based cohort study among 597 children and their mothers observed associations of maternal anemia in late pregnancy with wheezing and asthma until age 6 years, however we did not. Main differences between the studies that could explain the different findings are the period during pregnancy at which hemoglobin and hematocrit blood levels were measured, in the first pregnancy versus at delivery, the adjustment for gestational age at blood sampling or not, and the determinants definitions. Previous studies have shown that hemoglobin or hematocrit levels might change according to the pregnancy trimester evaluated 23 and that mothers are more likely to develop anemia in the third trimester. 31 Period in pregnancy at which maternal anemia is measured seems therefore important. Also, the age at which asthma was measured, and differences in study populations, a high-risk asthma population versus a populationbased cohort, might have influenced differences in results.
Maternal iron status during pregnancy may be used as proxy of the overall maternal nutritional status and also as a proxy of maternal anemia, since iron deficiency is a very common cause of anemia. 8 A previous study that examined the association of iron levels during pregnancy with asthma-related outcomes in children 32 suggested that lower maternal iron levels during pregnancy are associated with increased risks of wheezing and atopic sensitization in children whereas higher maternal iron levels during pregnancy are related to better lung function measures. Therefore, future studies need to focus on maternal hemoglobin and hematocrit in combination with iron levels status during multiple trimesters of pregnancy and the association with childhood lung function and asthma.
| Interpretation of results
The associations of maternal hemoglobin and hematocrit levels during pregnancy with childhood lung function might be explained by the importance of adequate oxygen and nutrients supply from the mother to the fetus in order to guarantee an adequate general and lung growth and development. [5] [6] [7] Low maternal hemoglobin levels may represent an insufficient oxygen supply to the fetus since the hemoglobin molecule is the oxygen carrier in our body. 33 High hemoglobin or hematocrit levels during pregnancy may lead to an important increase in the blood viscosity inducing an impaired blood flow through the placenta and, therefore, an insufficient oxygen supply to the fetus. Animal models have shown that undernutrition and hypoxia lead to an impaired lung development. 34, 35 In sheep, it has been shown that intrauterine exposure to hypoxia may inhibit lung growth and DNA synthesis. 34 A study in lambs fetuses showed that hypoxemia decreases pulmonary blood flow, which might lead to reduced oxygen and nutrients supply that could have an adverse impact on lung development. It has been suggested that in some circumstances the physiological plasma-volume expansion that usually occur in pregnancy may fail which could lead to relatively elevated hemoglobin or hematocrit levels during pregnancy. 36, 37 This would imply more viscous blood and could potentially lead to impaired placental perfusion and inappropriate blood and nutrients supply to the fetus. Our study showed that maternal elevated hematocrit levels were associated with lower lung function measures and might support the proposed hypothesis that maternal blood hyper viscosity during pregnancy influences fetal growth and lung development and later life lower lung function.
35
We observed that maternal anemia was associated with a high FEF in children. We analyzed hemoglobin and hematocrit levels mostly from blood samples obtained in the first trimester of pregnancy but hemoglobin or hematocrit levels might change according to the pregnancy trimester evaluated. 23 During early pregnancy, the mother is exposed to normal hemodynamic changes with an increase in the blood plasma disproportionally greater than increase of blood red cells numbers, which results in a physiologic anemia. Cohort studies have suggested that maternal physiologic anemia and iron deficiency anemia, which more often occurs in the third trimester, 31 might have different consequences to child health. 9, 10, 32 Iron deficiency seems associated with adverse child health outcomes while physiologic anemia seems to be associated with better outcomes for mother and child. Our results are in line with this hypothesis, although we were unable to assess the role of maternal iron status during pregnancy on lung function and asthma in children. It has also been suggested that the placenta might adapt to lower levels of hemoglobin or hematocrit leading to an increase in its vascular density. 11 This adaptive response could enhance fetal development, and our findings of maternal anemia leading to a high FEF could be attributed to this mechanism.
| Strengths and limitations
We used a population-based prospective cohort design from early pregnancy onwards, with detailed information on maternal and child characteristics and on maternal red blood status. Spirometry is the preferred method to assess lung function, 29, 30, 38 and to date this is the first study that uses this method as asthma-related outcome with maternal hemoglobin and hematocrit levels during pregnancy and long-term pulmonary outcomes under study. However, some limitations do apply. First, subjects lost to follow-up had less favorable social-economic status and lifestyle characteristics than those included in our study. This could have led to selection bias if the associations of maternal hemoglobin and hematocrit levels during pregnancy with childhood lung function and asthma would have been different between those subjects included and those lost to follow-up.
This seems unlikely, but needs to be considered. Additionally, we did not observe any differences between complete case analysis and multiple imputation, which suggests that any non-random missing data did not affect our results. 28 Second, we used self-reported data to define current asthma in our study population. Although we used treatment. Also, current asthma was measured subjectively by parental reports while lung function objectively by spirometry, which might partly explain the absence of associations of maternal hemoglobin and hematocrit levels with asthma diagnose itself.
In conclusion, our study suggests that higher maternal hematocrit levels are associated with lower lung function, and maternal anemia in analysis, interpretation of data, or writing of this report. The researchers are independent from the funders. The study sponsors had no role in the study design, data analysis, interpretation of data, or writing of this report.
